![Peter Birk](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter Birk
Directeur/Membre du Conseil chez CESSATECH A/S
Profil
Peter Birk is currently the Chairman at MonTa Biosciences ApS and an Independent Director at Cessatech A.
He has a graduate degree from the University of Southern Denmark and a doctorate degree from Institut National des Sciences Appliquées de Toulouse.
Postes actifs de Peter Birk
Sociétés | Poste | Début |
---|---|---|
CESSATECH A/S | Directeur/Membre du Conseil | 01/01/2020 |
MonTa Biosciences ApS
![]() MonTa Biosciences ApS BiotechnologyHealth Technology MonTa Biosciences ApS engages in research and development in biotechnology for cancer immunotherapy. Its technology offers a solution to deliver immune stimulating compounds directly to immune cells in the blood. The company was founded by Thomas Lars Andresen, Jonas Henriksen, and Simon Skjøde Jensen in August 2014 and is headquartered in Brønshøj, Denmark. | Président | - |
Formation de Peter Birk
Institut National des Sciences Appliquées de Toulouse | Doctorate Degree |
University of Southern Denmark | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
CESSATECH A/S | Health Technology |
Entreprise privées | 1 |
---|---|
MonTa Biosciences ApS
![]() MonTa Biosciences ApS BiotechnologyHealth Technology MonTa Biosciences ApS engages in research and development in biotechnology for cancer immunotherapy. Its technology offers a solution to deliver immune stimulating compounds directly to immune cells in the blood. The company was founded by Thomas Lars Andresen, Jonas Henriksen, and Simon Skjøde Jensen in August 2014 and is headquartered in Brønshøj, Denmark. | Health Technology |